Cargando…

Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis

BACKGROUND: Patients with chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT) who require dialysis are at increased risk for cardiovascular events and bone fractures. To assist in economic evaluations, this study aimed to estimate the disutility of these events beyond the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davies, Evan W., Matza, Louis S., Worth, Gavin, Feeny, David H., Kostelec, Jacqueline, Soroka, Steven, Mendelssohn, David, McFarlane, Philip, Belozeroff, Vasily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487205/ https://www.ncbi.nlm.nih.gov/pubmed/26122041 http://dx.doi.org/10.1186/s12955-015-0266-9

Ejemplares similares

Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease
por: Briggs, Andrew H., et al.
Publicado: (2019)

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
por: Hauber, Brett, et al.
Publicado: (2017)

Health state utilities associated with adult attention-deficit/hyperactivity disorder
por: Matza, Louis S, et al.
Publicado: (2014)

Healthcare use and costs before and after parathyroidectomy in patients on dialysis
por: Belozeroff, Vasily, et al.
Publicado: (2013)

Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism
por: McHorney, Colleen A., et al.
Publicado: (2018)

Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study
por: Chiroli, Silvia, et al.
Publicado: (2012)

Hyperparathyroidism in a diabetic patient on dialysis
por: Hori, Michiko, et al.
Publicado: (2008)

Health state utilities associated with attributes of treatments for hepatitis C
por: Matza, Louis S., et al.
Publicado: (2014)

Acute and chronic impact of cardiovascular events on health state utilities
por: Matza, Louis S, et al.
Publicado: (2015)

Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions
por: Matza, Louis S, et al.
Publicado: (2014)

Control of severe hyperparathyroidism in dialysis patients with nodular hyperplasia
por: Fukagawa, Masafumi, et al.
Publicado: (2008)

Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
por: Warady, Bradley A., et al.
Publicado: (2020)

Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s
por: Ketteler, Markus, et al.
Publicado: (2022)

An integrated review of "unplanned" dialysis initiation: reframing the terminology to "suboptimal" initiation
por: Mendelssohn, David C, et al.
Publicado: (2009)

The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation
por: Matza, Louis S., et al.
Publicado: (2015)

Ectopic ossification in the cranial dura mater in dialysis patients with secondary hyperparathyroidism
por: Oyama, Yuko, et al.
Publicado: (2010)

Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2019)

Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
por: Behets, Geert J, et al.
Publicado: (2015)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2016)

Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
por: Sun, Xiaoliang, et al.
Publicado: (2018)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
por: Abbas, Fizza, et al.
Publicado: (2019)

Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
por: Zhang, Yi, et al.
Publicado: (2019)

The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2019)

An assessment of dialysis provider’s attitudes towards timing of dialysis initiation in Canada
por: Mann, Bikaramjit S, et al.
Publicado: (2014)

Understanding Depression as It Occurs in the Context of Post-Traumatic Stress Disorder
por: Yehuda, Rachel, et al.
Publicado: (2012)

Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome
por: Mamedova, Elizaveta, et al.
Publicado: (2017)

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2017)

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
por: Frazão, João M, et al.
Publicado: (2012)

Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation
por: Xu, Zhou, et al.
Publicado: (2017)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
por: Roggeri, Alessandro, et al.
Publicado: (2020)

Hyperkalemia Following Parathyroidectomy in Patients with Renal Hyperparathyroidism—New Thresholds for Urgent Perioperative Dialysis
por: Bures, Claudia, et al.
Publicado: (2022)

Investigation of the Climatic and Environmental Context of Hendra Virus Spillover Events 1994–2010
por: McFarlane, Rosemary, et al.
Publicado: (2011)

Major orchestral works /
por: Mendelssohn-Bartholdy, Felix, 1809-1847
Publicado: (1975)

Major depression revealing primary hyperparathyroidism: A case report
por: Ouali, R., et al.
Publicado: (2021)

Association of Major Depressive Disorder in Hyperparathyroidism: A Systematic Review
por: Desai, Anjali, et al.
Publicado: (2023)

Parathyroidectomy Associates with Reduced Mortality in Taiwanese Dialysis Patients with Hyperparathyroidism: Evidence for the Controversy of Current Guidelines
por: Ho, Li-Chun, et al.
Publicado: (2016)

Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study
por: Roggeri, Daniela Paola, et al.
Publicado: (2014)

Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis
por: Park, Jee Eun, et al.
Publicado: (2016)

Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis
por: Weng, Cheng-Hao, et al.
Publicado: (2015)

Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
por: Ruderman, Irene, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ld8fn5id7mcsnqsaeugn4vmnhm